DEPRESS: Evaluation of Discomfort Associated With Scleral Depression During Retina Examinations

Sponsor
New York City Health and Hospitals Corporation (Other)
Overall Status
Completed
CT.gov ID
NCT04115917
Collaborator
(none)
87
1
2
13
6.7

Study Details

Study Description

Brief Summary

Scleral depression is an important technique used to examine the peripheral retina but often causes patient discomfort. The goal of this study was to compare levels of discomfort during scleral depression with a Schocket scleral depressor and cotton tipped applicator.

Condition or Disease Intervention/Treatment Phase
  • Device: Schocket scleral depressor
  • Device: Cotton tipped applicator
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
87 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
The first eye to undergo scleral depression was randomly assigned, then that eye was randomized two either of the scleral depression methods. The contralateral eye then had the alternative method of scleral depression performed.The first eye to undergo scleral depression was randomly assigned, then that eye was randomized two either of the scleral depression methods. The contralateral eye then had the alternative method of scleral depression performed.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Scleral Depression Pain With Schocket Depressor and Cotton Tipped Applicator: Depression Eye Pain Relief Evaluation Study (DEPRESS)
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Dec 31, 2018
Actual Study Completion Date :
Jan 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Schocket Scleral Depressor

Scleral Depression with Schocket Scleral Depressor

Device: Cotton tipped applicator
Scleral Depression on eye with cotton tipped applicator

Active Comparator: Cotton Tipped Applicator

Scleral Depression with Cotton Tipped Applicator

Device: Schocket scleral depressor
Scleral Depression on eye with Schocket scleral depressor

Outcome Measures

Primary Outcome Measures

  1. Discomfort During Scleral Depression with Schocket Depressor and Cotton Tipped Applicator [Pain evaluated immediately scleral depression was completed on the eye]

    Visual Analog Scale (VAS) was used to evaluate pain immediately after scleral depression was completed. The VAS scale used was a 100mm long line with 0 representing no pain at all and 100 representing the worst pain possible.

Secondary Outcome Measures

  1. Hemoglobin A1c [1 year]

    The association of discomfort experienced during scleral depression and the patients hemoglobin A1c.

  2. Spherical Equivalent of Glasses Prescription [1 day]

    The association of discomfort experienced during scleral depression and the patients spherical equivalent of their glasses prescription.

  3. Age [1 day]

    The association of discomfort experienced during scleral depression and the patients age based on those less than 65 versus those greater than 65 years of age

  4. Left Eye vs Right Eye [1 day]

    The association of discomfort experienced during scleral depression and the patients left and right eyes. Of note, each eye had a separate method of scleral depression performed.

  5. Retinal pathology [1 day]

    Discomfort during scleral depression in participants with peripheral retinal tears or holes versus patients with no peripheral retinal pathology.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult patients who received dilated eye examinations in the retina or general eye clinic
Exclusion Criteria:
  • Younger than 18

  • Pregnant

  • Prior scleral buckle, filtering bleb or underwent any other ocular surgery within the past month

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kings County Hospital Brooklyn New York United States 11203

Sponsors and Collaborators

  • New York City Health and Hospitals Corporation

Investigators

  • Principal Investigator: Joseph J Raevis, MD, Kings County Hospital

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Joseph Raevis, Ophthalmologist, New York City Health and Hospitals Corporation
ClinicalTrials.gov Identifier:
NCT04115917
Other Study ID Numbers:
  • JJR666
First Posted:
Oct 4, 2019
Last Update Posted:
Oct 4, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Joseph Raevis, Ophthalmologist, New York City Health and Hospitals Corporation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 4, 2019